Page 28 - மருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Human Trials of ZF2001 Vaccine report no infection--China Economic Net

Human Trials of ZF2001 Vaccine report no infection--China Economic Net
en.ce.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from en.ce.cn Daily Mail and Mail on Sunday newspapers.

Wang suAgha khan hospitalShehnoor azharYasir habib khanSajid shahDrug regulatory authority of pakistanAnhui zhifei longcom biologic pharmacy coInstitute of biotechnology chinaInstitute of biological productsNational defense hospitalUniversity of health sciencesChina cansino biologics incMinistry of national health servicesPakistani embassyYasir habibHealth sciences

Here s a Comparison of All Vaccines Approved in Pakistan

Here s a Comparison of All Vaccines Approved in Pakistan
propakistani.pk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from propakistani.pk Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSouth africaUnited arab emiratesSaudi arabiaSouth koreaCansino biologicsSinovac biotechDrug regulatory authority of pakistanChina national pharmaceutical group corporationGamaleya research institute of epidemiologyGamaleya instituteOxford universitySerum institute of indiaDrug regulatory authorityEmergency use authorization

DRAP directive to provinces: Ensure doctors prescribed drugs with generic names

National April 19, 2021 LAHORE: The Drug Regulatory Authority of Pakistan (DRAP) has directed all provincial governments to ensure that doctors prescribe medicines with their generic names in public and private sector in the country. The DRAP issued the order in response to public complaints on PM’s citizens’ portal against pharmaceutical companies and doctors’ collusion to rip off of the people through prescription and sale of costlier medicines under brand name. In a letter to secretaries of health departments of all four provinces, Azad Jammu Kashmir (AJK) and Gilgit-Baltistan (GB) and Commissioner of Islamabad Capital Territory (ICT), DRAP’s Director Pharmacy Services Dr Abdur Rasheed said the citizens had complained through Prime Minister’s Performance Delivery Unit (PMDU) against company-influenced brand-based prescription of medicines by doctors in government and private sectors. This practice adds to the economic burden of the country, and also puts financial l

Islamabad capital territoryGilgit baltistanNorthern areasNoor maharDrug regulatory authority of pakistanDrug lawyer forumPharmacy services dr abdur rasheedDrug regulatory authorityAzad jammu kashmirPrime ministerPerformance delivery unitDrug actஇஸ்லாமாபாத் மூலதனம் பிரதேசம்வடக்கு பகுதிகள்மருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான்மருந்து வழக்கறிஞர் மன்றம்

Drug brand names in prescriptions banned

Drug brand names in prescriptions banned Islamabad April 19, 2021 Islamabad : The Drug Regulatory Authority of Pakistan (DRAP) has stopped medical practitioners from writing brand names of drugs in prescriptions. In a circular, the DRAP said it was unlawful for doctors to write the names of medicine manufacturers in their prescriptions. “It is a common practice that the private as well as government hospitals’ doctors write the ‘brand name’ of a medicine in their prescriptions with expensive price. “The patients become overburdened to purchase expensive medicines of a specific brand,” it said. The DRAP said in future, medical practitioners would write generic formulas of medicines instead of their brand names.

Drug regulatory authority of pakistanDrug regulatory authorityPrime ministerPerformance delivery unitமருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான்மருந்து ஒழுங்குமுறை அதிகாரம்ப்ரைம் அமைச்சர்செயல்திறன் டெலிவரி அலகு

DRAP directive to provinces: Ensure doctor prescribed drug with generic names

National April 19, 2021 LAHORE: The Drug Regulatory Authority of Pakistan (DRAP) has directed all provincial governments to ensure that doctors prescribe medicines with their generic names in public and private sector in the country. The DRAP issued the order in response to public complaints on PM’s citizens’ portal against pharmaceutical companies and doctors’ collusion to rip off of the people through prescription and sale of costlier medicines under brand name. In a letter to secretaries of health departments of all four provinces, Azad Jammu Kashmir (AJK) and Gilgit-Baltistan (GB) and Commissioner of Islamabad Capital Territory (ICT), DRAP’s Director Pharmacy Services Dr Abdur Rasheed said the citizens had complained through Prime Minister’s Performance Delivery Unit (PMDU) against company-influenced brand-based prescription of medicines by doctors in government and private sectors. This practice adds to the economic burden of the country, and also puts financial l

Islamabad capital territoryGilgit baltistanNorthern areasNoor maharDrug regulatory authority of pakistanDrug lawyer forumPharmacy services dr abdur rasheedDrug regulatory authorityAzad jammu kashmirPrime ministerPerformance delivery unitDrug actஇஸ்லாமாபாத் மூலதனம் பிரதேசம்வடக்கு பகுதிகள்மருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான்மருந்து வழக்கறிஞர் மன்றம்